Successful treatment of fulminant pulmonary hemorrhage associated with systemic lupus erythematosus

Clinical Rheumatology

Volumn 23, Issue 3, 2004, Pages 252-255

  Hoshi, Ken Ichi ^a   Matsuda, Masayuki ^a   Ishikawa, Mariko ^a   Mitsuhashi, Shigeaki ^a   Gono, Takahisa ^a   Hashimoto, Takao ^a   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hemophagocytic syndrome; High dose intravenous immunoglobulin; Plasmapheresis; Pulmonary hemorrhage; Systemic lupus erythematosus; Tacrolimus

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; FERRITIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALOPECIA; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CONTINUOUS INFUSION; DISEASE COURSE; DOSE RESPONSE; DRUG MEGADOSE; FATALITY; FEMALE; FREQUENCY ANALYSIS; HELPER CELL; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERFERRITINEMIA; LIVER DYSFUNCTION; LUNG HEMORRHAGE; MACROPHAGE; NEPHROTOXICITY; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCTIVE TOXICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; FEMALE; HEMORRHAGE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLASMAPHERESIS; TACROLIMUS; TREATMENT OUTCOME;

EID: 3042539335     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0859-2     Document Type: Article

References (22)

1. D'Cruz D, Khamashta M, Hughes G (2002) Pulmonary manifestations of systemic lupus erythematosus. In: DJ Wallace et al (eds) Dubois' lupus erythematosus, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 663-683
2. Domingo-Pedrol P, Rodriguez de la Serna A, Mancebo-Cortes J, Sanchez-Segura JM (1985) Adult respiratory distress syndrome caused by acute systemic lupus erythematosus. Eur J Respir Dis 67:141-144
3. Asherson RA, Ridley M, Fletcher CD, Hughes GR (1988) Systemic lupus erythematosus, pulmonary hypertension and adult respiratory distress syndrome (ARDS). Clin Exp Rheumatol 6:301-304
4. Kim WU, Kim SI, Yoo WH et al. (1999) Adult respiratory distress syndrome in systemic lupus erythematosus: causes and prognostic factors: a single center, retrospective study. Lupus 8:552-557
5. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
6. Hallegua DS, Wallace DJ (2002) Gastrointestinal and hepatic manifestations. In: DJ Wallace et al (eds) Dubois' lupus erythematosus, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 843-861
7. Henter J-I, Elinder G, Öst Å (1999) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 18:29-33
8. Ravelli A (2002) Macrophage activation syndrome. Curr Opin Rheumatol 14:548-552
9. Green RJ, Ruoss SJ, Kraft SA, Duncan SR, Berry GJ, Raffin TA (1996) Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest 110:1305-1316
10. Jara LJ, Vera-Lastra O, Calleja MC (2003) Pulmonary-renal vasculitic disorders: differential diagnosis and management. Curr Rheumatol Rep 5:107-115
11. Lauqua D, Cadranel J, Lazor R et al. (2000) Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Medicine (Baltimore) 79:222-233
12. Eagen JW, Memoli VA, Roberts JL, Matthew GR, Schwartz MM, Lewis EJ (1978) Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 57:545-560
13. Moss M, Ingram RH Jr (2001) Acute respiratory distress syndrome, In: E Braunwald et al. (eds) Harrison's principles of internal medicine, 15th edn. McGraw-Hill, New York, pp 1523-1526
14. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM (1992) A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 326:1373-1379
15. Erickson RW, Franklin WA, Emlen W (1994) Treatment of hemorrhagic lupus pneumonitis with plasmapheresis. Semin Arthritis Rheum 24:114-123
16. Dalakas MC (1998) Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51 (Suppl): S2-8
17. Kilian K, Banyai A, Karadi A, Miklos K, Patranyi GG, Paloczi K (1998) FK-506 (tacrolimus) therapy for an unusual SLE-like disease. Transplant Proc 30:4130-4131
18. Griffiths B, Emery P (2001) The treatment of lupus with cyclosporin A. Lupus 10:165-170
19. Manger K, Kalden JR, Manger B (1996) Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study. Br J Rheumatol 35:669-675
20. Schreiber SL, Crabtree GR (1992) The mechanism of action of cyclosporin A and FK506. Immunol Today 13:136-142
21. Moon JI, Park SG, Cheon KO (2000) Pregnancy in renal transplant patients. Transplant Proc 32:1869-1870
22. Yasuhara M, Hashida T, Toraguchi M et al. (1995) Pharmacokinetics and pharmacodynamics of FK506 in pediatric patients receiving living-related donor liver transplantation. Transplantation Proc 27:1108-1110